Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 256Recruiting 65Unknown 53Not yet recruiting 43Terminated 26Active not recruiting 20Withdrawn 15Enrolling by invitation 13Suspended 2

Sponsor Class

OTHER 2

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Neoplasms 35Breast Neoplasms 30Prostatic Neoplasms 22Leukemia, Myeloid, Acute 20Colorectal Neoplasms 20Melanoma 17Pancreatic Neoplasms 16Glioblastoma 16Carcinoma, Non-Small-Cell Lung 16Neoplasm Metastasis 15Lung Neoplasms 13Brain Neoplasms 13Glioma 12Stomach Neoplasms 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Myelodysplastic Syndromes 11Carcinoma, Hepatocellular 11Ovarian Neoplasms 10Multiple Myeloma 9Head and Neck Neoplasms 9Triple Negative Breast Neoplasms 8Lymphoma 8Carcinoma, Renal Cell 8Leukemia 7Sarcoma 6Rectal Neoplasms 6Hematologic Neoplasms 6Esophageal Neoplasms 6Uterine Cervical Neoplasms 5Recurrence 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Interventional × Anxiety Disorders × Clear all
NCT06213298 2026-02-11

Effect of Kava on Anxiety and Stress in Cancer Survivors

Masonic Cancer Center, University of Minnesota

Phase EARLY_PHASE1 Suspended
43 enrolled

Anxiety Disorders, Depression, Neoplasms

NCT01772498 2015-05-06

HRV Biofeedback for Brain Tumour Survivors

British Columbia Cancer Agency

Phase NA Suspended
15 enrolled

Anxiety Disorders, Depression, Pain, Respiratory Aspiration

Data powered by HemOnc (CC BY 4.0) Colophon âš¡